PHARMACYTE BIOTECH, INC. Dividends, Preferred Stock, Paid-in-kind
PHARMACYTE BIOTECH, INC. (PMCB) reported Dividends, Preferred Stock, Paid-in-kind of $32.49 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockPaidinkind · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. dividends, preferred stock, paid-in-kind for the quarter ending 2026-07-31 was $32.49K.
- PHARMACYTE BIOTECH, INC. dividends, preferred stock, paid-in-kind for the quarter ending 2026-01-31 was $32.49K.
- PHARMACYTE BIOTECH, INC. dividends, preferred stock, paid-in-kind for the quarter ending 2025-10-31 was $35.39K.
- PHARMACYTE BIOTECH, INC. dividends, preferred stock, paid-in-kind for fiscal 2026 was $32.49K.
| Period end | Dividends, Preferred Stock, Paid-in-kind 3 month | Dividends, Preferred Stock, Paid-in-kind 6 month | Dividends, Preferred Stock, Paid-in-kind 12 month |
|---|---|---|---|
| 2026-07-31 | $32.49K 10-Q · filed 2026-09-14 | ||
| 2026-04-30 | $32.49K 10-K · filed 2026-07-29 | ||
| 2026-01-31 | $32.49K 10-Q · filed 2026-03-17 | $67.88K derived: sum of 2 quarters · filed 2026-03-17 | |
| 2025-10-31 | $35.39K 10-Q · filed 2025-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |